MyFinsight
Home
About
Contact
anip: the income statement
Download
Download image
Sales Of ILUVIENAnd
YUTIQ
$16,600K
Sales Of Cortrophin
Gel
$101,850K
Sales Of Royalties And
Other Pharmaceutical...
$4,313K
Sales Of Generic
Pharmaceutical Products
$94,375K
Sales Of Established
Brands
$10,675K
Total Sales Of Rare
Disease Pharmaceutical...
$118,450K
Total Sales Of
Generics And Other
$98,688K
Total Sales Of Rare
Disease And Brands
$129,125K
Net revenues
$227,813K
(53.58%↑ Y/Y)
Unrealized gain on
investment in equity...
$3,140K
(131.73%↑ Y/Y)
Operating income (loss)
$36,240K
(276.62%↑ Y/Y)
Total operating
expenses, net
$191,573K
(13.46%↑ Y/Y)
Contingent consideration
fair value...
-$14,470K
(-1853.94%↓ Y/Y)
Income (loss) before
income tax expense...
$33,800K
(207.31%↑ Y/Y)
Other (expense)
income, net
-$853K
(66.35%↑ Y/Y)
Interest expense, net
-$4,727K
(-102.79%↓ Y/Y)
Intangible asset
impairment charge
$767K
Loss (gain) on
disposal of assets
-$295K
Depreciation and
amortization
$22,632K
(43.71%↑ Y/Y)
Selling, general, and
administrative
$76,656K
(-3.06%↓ Y/Y)
Research and development
$12,304K
(21.48%↑ Y/Y)
Cost of sales
(excluding depreciation...
$93,389K
(48.06%↑ Y/Y)
Net income (loss)
$26,617K
(210.14%↑ Y/Y)
Income tax expense
(benefit)
$7,183K
(197.97%↑ Y/Y)
Net income (loss)
available to common...
$26,273K
(206.92%↑ Y/Y)
Dividends on series a
convertible preferred stock
$344K
(-15.27%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
ANI PHARMACEUTICALS INC (ANIP)
ANI PHARMACEUTICALS INC (ANIP)